Citation Impact

Citing Papers

Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes
2018 StandoutScienceNobel
Resting Microglial Cells Are Highly Dynamic Surveillants of Brain Parenchyma in Vivo
2005 StandoutScience
Mouse Hepatitis Virus Infection of the Central Nervous System: Chemokine-Mediated Regulation of Host Defense and Disease
2002
MHV Infection of the CNS: Mechanisms of Immune-Mediated Control
2001
T Cell Antiviral Effector Function Is Not Dependent on CXCL10 Following Murine Coronavirus Infection
2006
Molecular mechanisms underlying ErbB2/HER2 action in breast cancer
2000
Heregulin selectively upregulates vascular endothelial growth factor secretion in cancer cells and stimulates angiogenesis
2000
Biochemical and Clinical Implications of the ErbB/HER Signaling Network of Growth Factor Receptors
1999
Alternative Intracellular Routing of ErbB Receptors May Determine Signaling Potency
1998
Cardiotoxicity in signal transduction therapeutics: ErbB2 antibodies and the heart
2001
EGFR Antagonists in Cancer Treatment
2008 Standout
MYC on the Path to Cancer
2012 Standout
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
2010 Standout
A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
2010 Standout
Oncogenic kinase signalling
2001 StandoutNature
Glutamate uptake
2001 Standout
Cell Signaling by Receptor Tyrosine Kinases
2010 Standout
Pro-resolving lipid mediators are leads for resolution physiology
2014 StandoutNature
Evaluation of protein kinase activities of cell lysates using peptide microarrays based on surface plasmon resonance imaging
2008
The ErbB-2/HER2 oncogenic receptor of adenocarcinomas: from orphanhood to multiple stromal ligands
1998
FTY720 modulates human oligodendrocyte progenitor process extension and survival
2007
Role of Ca2+-independent phospholipase A2 in cell growth and signaling
2008
Resolvin D1 Receptor Stereoselectivity and Regulation of Inflammation and Proresolving MicroRNAs
2012
Regulation of Neuregulin Signaling by PSD-95 Interacting with ErbB4 at CNS Synapses
2000
Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer
2004 Standout
Dynamic control over cell adhesive properties using molecular-based surface engineering strategies
2009 StandoutNobel
Differential roles for CXCR3 in CD4+ and CD8+ T cell trafficking following viral infection of the CNS
2006
Neurophysiological investigation of the basis of the fMRI signal
2001 StandoutNature
ErbB-4: mechanism of action and biology
2003
Multifunctional Peptide-Conjugated Hybrid Silica Nanoparticles for Photodynamic Therapy and MRI
2012
The Immunomodulator FTY720 Has a Direct Cytoprotective Effect in Oligodendrocyte Progenitors
2007
Multiple sclerosis
2008 Standout
β-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression
2005 StandoutNature
Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
2005 Standout
DNA Methylation, Behavior and Early Life Adversity
2013
Distribution and phenotype of neurons containing the ATP-sensitive K+ channel in rat brain
1998
Psoriasis
2015 Standout
Characterization of a naturally occurring ErbB4 isoform that does not bind or activate phosphatidyl inositol 3-kinase
1999
Genetics of human prefrontal function
2003
In vivo 13C NMR studies of compartmentalized cerebral carbohydrate metabolism
2002
Trastuzumab — Mechanism of Action and Use in Clinical Practice
2007 Standout
Functional Diversity of Chemokines and Chemokine Receptors in Response to Viral Infection of the Central Nervous System
2006
Central nervous system control of food intake
2000 StandoutNature
Molecular prognostic markers in pancreatic cancer: A systematic review
2005
Glial and neuronal control of brain blood flow
2010 StandoutNature
Chemical modulators of sphingosine-1-phosphate receptors as barrier-oriented therapeutic molecules
2009
The role of EGF-related peptides in tumor growth
2001
FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system
2009
Cortical GABA Interneurons in Neurovascular Coupling: Relays for Subcortical Vasoactive Pathways
2004
Multipotent Flk-1+ Cardiovascular Progenitor Cells Give Rise to the Cardiomyocyte, Endothelial, and Vascular Smooth Muscle Lineages
2006
G Protein-coupled Receptor Kinase 5 Regulates β1-Adrenergic Receptor Association with PSD-95
2002 StandoutNobel
Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
2013 StandoutNature
Regulation of Mouse Mammary Gland Development and Tumorigenesis by the ERBB Signaling Network
2001
Deceiving appearances: signaling by “dead” and “fractured” receptor protein-tyrosine kinases
2000
Epiregulin Is a Potent Pan-ErbB Ligand That Preferentially Activates Heterodimeric Receptor Complexes
1998
NEW EMBO MEMBERS' REVIEW: The ErbB signaling network: receptor heterodimerization in development and cancer
2000 Standout
Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis
2010
Oral Fingolimod (FTY720) for Relapsing Multiple Sclerosis
2006
Sphingosine 1-phosphate receptors in health and disease: Mechanistic insights from gene deletion studies and reverse pharmacology
2007
Developing Inhibitors of the Epidermal Growth Factor Receptor for Cancer Treatment
2003
Direct Reprogramming of Fibroblasts into Functional Cardiomyocytes by Defined Factors
2010 Standout
The P2Y12 receptor regulates microglial activation by extracellular nucleotides
2006 StandoutNobel
Effects of perinatal mental disorders on the fetus and child
2014 Standout
Cytokine Signaling in 2002
2002 Standout
The PI3K Pathway in Human Disease
2017 Standout
Ubiquitin Ligase Activity and Tyrosine Phosphorylation Underlie Suppression of Growth Factor Signaling by c-Cbl/Sli-1
1999 StandoutNobel
Genes that mediate breast cancer metastasis to lung
2005 StandoutNature
Deregulation of Glucose Transporter 1 and Glycolytic Gene Expression by c-Myc
2000
Epidermal growth factor receptor (EGFR) signaling in cancer
2005 Standout
Microglia
2004
Early activation, motility, and homing of neonatal microglia to injured neurons does not require protein synthesis
2006
Brain Penetration of the Oral Immunomodulatory Drug FTY720 and Its Phosphorylation in the Central Nervous System during Experimental Autoimmune Encephalomyelitis: Consequences for Mode of Action in Multiple Sclerosis
2007
Cell Signaling by Receptor Tyrosine Kinases
2000 Standout
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
2020 Standout
Neuregulin-4: a novel growth factor that acts through the ErbB-4 receptor tyrosine kinase
1999
Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis
2007 Standout
Neuregulin-3 (NRG3): A novel neural tissue-enriched protein that binds and activates ErbB4
1997
Lack of CCR2 Results in Increased Mortality and Impaired Leukocyte Activation and Trafficking Following Infection of the Central Nervous System with a Neurotropic Coronavirus
2001
Targeted inactivation of the EGF and amphiregulin genes reveals distinct roles for EGF receptor ligands in mouse mammary gland development
1999
Directed and Systematic Differentiation of Cardiovascular Cells From Mouse Induced Pluripotent Stem Cells
2008 StandoutNobel
Stat1-independent regulation of gene expression in response to IFN-γ
2001
CXC Chemokine Ligand 10 Controls Viral Infection in the Central Nervous System: Evidence for a Role in Innate Immune Response through Recruitment and Activation of Natural Killer Cells
2003
The Protein Kinase Complement of the Human Genome
2002 StandoutScience
Oral fingolimod (FTY720) in multiple sclerosis
2009
New Strategies for Fluorescent Probe Design in Medical Diagnostic Imaging
2009 Standout
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
HER2 (neu) Signaling Increases the Rate of Hypoxia-Inducible Factor 1α (HIF-1α) Synthesis: Novel Mechanism for HIF-1-Mediated Vascular Endothelial Growth Factor Expression
2001 StandoutNobel
Human Dendritic Cells Activate Resting Natural Killer (NK) Cells and Are Recognized via the NKp30 Receptor by Activated NK Cells
2002 StandoutNobel
Nanoparticles in Photodynamic Therapy
2015 Standout
Expression of Mig (Monokine Induced by Interferon-γ) Is Important in T Lymphocyte Recruitment and Host Defense Following Viral Infection of the Central Nervous System
2001
Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization.
1994 Standout
Evidence for Differential Roles for NKG2D Receptor Signaling in Innate Host Defense against Coronavirus-Induced Neurological and Liver Disease
2007 StandoutNobel
Control of protein signaling using a computationally designed GTPase/GEF orthogonal pair
2012
Antibody Targeting of the CC Chemokine Ligand 5 Results in Diminished Leukocyte Infiltration into the Central Nervous System and Reduced Neurologic Disease in a Viral Model of Multiple Sclerosis
2004
CC Chemokine Ligand 3 (CCL3) Regulates CD8+-T-Cell Effector Function and Migration following Viral Infection
2003
Neutralization of the Chemokine CXCL10 Reduces Inflammatory Cell Invasion and Demyelination and Improves Neurological Function in a Viral Model of Multiple Sclerosis
2001
Psychological Stress and the Cutaneous Immune Response: Roles of the HPA Axis and the Sympathetic Nervous System in Atopic Dermatitis and Psoriasis
2012
Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization
2010 Standout
Expression of CXC Chemokine Ligand 10 from the Mouse Hepatitis Virus Genome Results in Protection from Viral-Induced Neurological and Liver Disease
2007 StandoutNobel
Coronavirus Pathogenesis and the Emerging Pathogen Severe Acute Respiratory Syndrome Coronavirus
2005
Rapid metabolic evolution in human prefrontal cortex
2011 StandoutNobel
Cutting Edge: The T Cell Chemoattractant IFN-Inducible Protein 10 Is Essential in Host Defense Against Viral-Induced Neurologic Disease
2000
MyD88 signaling in nonhematopoietic cells protects mice against induced colitis by regulating specific EGF receptor ligands
2010 StandoutNobel
Phospholipase A2Enzymes: Physical Structure, Biological Function, Disease Implication, Chemical Inhibition, and Therapeutic Intervention
2011 Standout
Macrophage Infiltration, but Not Apoptosis, Is Correlated with Immune-Mediated Demyelination following Murine Infection with a Neurotropic Coronavirus
1999
NATURAL KILLER CELLS IN ANTIVIRAL DEFENSE: Function and Regulation by Innate Cytokines
1999 Standout
A Central Role for CD4+T Cells and RANTES in Virus-Induced Central Nervous System Inflammation and Demyelination
2000

Works of Naichen Yu being referenced

Live Cell Quality Control and Utility of Real-Time Cell Electronic Sensing for Assay Development
2006
Dynamic Regulation of α- and β-Chemokine Expression in the Central Nervous System During Mouse Hepatitis Virus-Induced Demyelinating Disease
1998
IL-1-Alpha and TNF-Alpha Differentially Regulate CD4 and Mac-1 Expression in Mouse Microglia
1998
VIP receptor subtypes in mouse cerebral cortex: evidence for a differnntial localization in astrocytes, microvessels and synaptosomal membranes
1992
Sphingosine 1-phosphate receptor agonists attenuate relapsing–remitting experimental autoimmune encephalitis in SJL mice
2004
Inflammatory cytokines: putative regulators of neuronal and neuro-endocrine function1Published on the World Wide Web on 24 October 1997.1
1998
Label-Free and Real-Time Cell-Based Kinase Assay for Screening Selective and Potent Receptor Tyrosine Kinase Inhibitors Using Microelectronic Sensor Array
2006
Neuregulin-2, a new ligand of ErbB3/ErbB4-receptor tyrosine kinases
1997 Nature
Characterization of lysophosphatidic acid and sphingosine‐1‐phosphate‐mediated signal transduction in rat cortical oligodendrocytes
2003
Pharmacological characterization of lysophospholipid receptor signal transduction pathways in rat cerebrocortical astrocytes
2003
Neurotransmitters Regulate Energy Metabolism in Astrocytes: Implications for the Metabolic Trafficking between Neural Cells
1993
Tumor necrosis factor-alpha and interleukin-1 alpha enhance glucose utilization by astrocytes: involvement of phospholipase A2.
1995
Microglial activation state and lysophospholipid acid receptor expression
2003
Inhibition of Astrocyte Glutamate Uptake by Reactive Oxygen Species: Role of Antioxidant Enzymes
1997
Growth factor pre‐treatment differentially regulates phosphoinositide turnover downstream of lysophospholipid receptor and metabotropic glutamate receptors in cultured rat cerebrocortical astrocytes
2004
Effects of feline immunodeficiency virus on astrocyte glutamate uptake: Implications for lentivirus-induced central nervous system diseases
1998
Dynamic regulation of alpha- and beta-chemokine expression in the central nervous system during mouse hepatitis virus-induced demyelinating disease.
1998
Arachidonic acid stimulates glucose uptake in cerebral cortical astrocytes.
1993
Real-Time Monitoring of Morphological Changes in Living Cells by Electronic Cell Sensor Arrays:  An Approach To Study G Protein-Coupled Receptors
2005
Rankless by CCL
2026